Using Exercise to Enhance Fear Extinction Learning

April 20, 2026 updated by: Josh Cisler

Efficacy and Mechanisms of Exercise-Enhanced Fear Extinction

The goal of the current project is to establish the efficacy and mechanisms of exercise-enhanced fear extinction retrieval and generalization in posttraumatic stress disorder (PTSD). Exposure therapy is the gold standard treatment for PTSD, yet is only associated with remission rates of ~55% and in clear need of improvement. Exposure therapy is hypothesized to work through mechanisms of fear extinction learning, and as such, laboratory-based fear extinction paradigms are widely used as models of exposure therapy. Recent data demonstrates that moderate-intensity aerobic exercise, delivered specifically during or after fear extinction learning, can boost the consolidation of fear extinction learning. Consistent with emerging models of exercise's pro-extinction effect, our pilot data among women with PTSD found that moderate intensity aerobic exercise delivered after fear extinction learning leads to a reduction in subsequent fear responding 24hrs later, an effect that was mediated by exercise-induced increases in peripheral brain derived neurotrophic factor (BDNF). Our pilot data using multivariate pattern analyses (MVPA) also identified divided neurocircuitry organization of fear vs safety memories, and that this divided neural organization was altered in PTSD. Building on our pilot data, the current project would 1) compare the impact of different intensities of exercise delivered following fear extinction learning on multimodal measures of fear extinction retrieval and generalization, 2) identify the impact of exercise on MVPA representations of fear vs safety memories, and 3) demonstrate that spontaneous reactivations of extinction encodings in the acute consolidation window operate as candidate mechanisms by which exercise enhances extinction retrieval and generalization. Using a 3-day fear conditioning, fear extinction, and fear extinction retrieval and recognition task during functional magnetic resonance imaging (fMRI), 200 adults with PTSD would be randomly assigned to either resting control or 30min of either light, moderate, or high intensity exercise. Testing dose-response relationships between exercise intensity and fear extinction will inform translation of this research to clinical settings. A one week-follow-up extinction retrieval test would investigate the impact of exercise on longer-term retention. This project would provide a critical evaluation of the impact of aerobic exercise on consolidation and recall of extinction learning in PTSD samples, thereby providing a strong foundation to translate this research to clinical care and enhance clinical outcomes for PTSD. The project would also provide general knowledge regarding dose-response relationships and neural mechanisms that support enhanced extinction, thereby informing development of additional novel treatments.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age 18 - 55 years of age
  • Currently experiencing at least 4 PTSD symptoms with at least 1 re-experiencing symptom (e.g., trauma memory intrusion, trauma nightmares, trauma flashbacks, intense emotional distress related to trauma, or marked physiological reactivity related to trauma) from criterion B.
  • English speaking
  • Medically healthy

Exclusion Criteria:

  • being pregnant
  • having a history of light headedness or fainting during physical activity
  • having a history of chest pain during physical activity
  • having a bone, joint, cardiac, or other medical condition that a doctor has said may be worsened by physical activity
  • responding 'Yes' to any of the seven questions on the Physical Activity Readiness Questionnaire (PAR-Q; unless they provide a doctor's note indicating that it is safe for them to engage in aerobic exercise )
  • percutaneous coronary intervention or acute myocardial infarction in the last 6 weeks
  • unstable arrhythmias/implanted cardiac defibrillator shocks in the last 3 months
  • Internal ferromagnetic objects (such as electronic devices, surgical implants, shrapnel, etc.)
  • Nonremovable dental implants, such as braces or upper permanent retainers, as these will distort the MRI images we collect (note: filings, crowns, and silver or gold teeth are OK)
  • Any other condition, medication, or implant that the investigator believes would degrade image quality or render data unusable
  • psychotic disorders
  • Permanent makeup or tattoos with metallic dyes,
  • A self-reported history of loss of consciousness (greater than 30 minutes)
  • physical disabilities that prohibit task performance (such as blindness or deafness)
  • Any other condition that the investigator believes might put the participant at risk
  • Claustrophobia
  • History of cardiovascular disease
  • on-going traumatic event exposure (e.g., living with an abusive partner)
  • Severe substance use disorder.
  • unstable medication (changes within the past ~4 weeks)
  • Acute sedatives/pain killers (e.g., benzodiazepines, Vicodin) and prescription stimulants (e.g., Adderall) would not be permitted for 6 hours prior to the study visit.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High-Intensity Exercise
High intensity exercise on a seated cycle for 26 minutes
Exercise consists of a total duration of 26 minutes on a seated exercise cycle. Exercise begins with a 3min warm-up, 20min of exercise at the desired intensity range, and then a 3min cool-down. During exercise, heart rate is monitored and perceived effort is assessed every 2 minutes.
Experimental: Moderate-Intensity Exercise
moderate intensity exercise on a seated cycle for 26 minutes
Exercise consists of a total duration of 26 minutes on a seated exercise cycle. Exercise begins with a 3min warm-up, 20min of exercise at the desired intensity range, and then a 3min cool-down. During exercise, heart rate is monitored and perceived effort is assessed every 2 minutes.
Experimental: Light-Intensity Exercise
Light intensity exercise on a seated cycle for 26 minutes
Exercise consists of a total duration of 26 minutes on a seated exercise cycle. Exercise begins with a 3min warm-up, 20min of exercise at the desired intensity range, and then a 3min cool-down. During exercise, heart rate is monitored and perceived effort is assessed every 2 minutes.
No Intervention: Quiet Rest

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Threat Expectation
Time Frame: Threat expectation to conditioned stimuli is measured with a 4pt Likert Scale (range 0-3) in response to conditioned stimuli, using self-report, as a measure of cognitive features of fear, one day after intervention and 7-13 days after intervention.
Threat expectation is a cognitive process and measure of fear towards conditioned stimuli
Threat expectation to conditioned stimuli is measured with a 4pt Likert Scale (range 0-3) in response to conditioned stimuli, using self-report, as a measure of cognitive features of fear, one day after intervention and 7-13 days after intervention.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Skin Conductance Responses (SCRs)
Time Frame: SCR is assessed on the palms in response to conditioned stimuli, using BIOPAC equipment, as a measure of sympathetic arousal, one day after intervention and 7-13 days after intervention.
skin conductance response is a measure of sympathetic arousal and is measured on the palms using BIOPAC equipment
SCR is assessed on the palms in response to conditioned stimuli, using BIOPAC equipment, as a measure of sympathetic arousal, one day after intervention and 7-13 days after intervention.
BOLD Activation to CS+ and CS-
Time Frame: BOLD activity to conditioned stimuli is measured during fMRI in response to conditioned stimuli, using 3T Siemens Prisma, as a measure of neural activity, one day after intervention and 7-13 days after intervention.
blood oxygen level dependent (BOLD) response measured during fMRI provides an assessment of neural activity
BOLD activity to conditioned stimuli is measured during fMRI in response to conditioned stimuli, using 3T Siemens Prisma, as a measure of neural activity, one day after intervention and 7-13 days after intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 2, 2025

Primary Completion (Estimated)

May 1, 2030

Study Completion (Estimated)

May 1, 2030

Study Registration Dates

First Submitted

April 14, 2026

First Submitted That Met QC Criteria

April 20, 2026

First Posted (Actual)

April 23, 2026

Study Record Updates

Last Update Posted (Actual)

April 23, 2026

Last Update Submitted That Met QC Criteria

April 20, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on PTSD

Clinical Trials on Exercise

Subscribe